Herliawati, P. A. ., Harnandari, D. E. P. ., Hildayanti, R. A. ., Wicaksana, A. ., & Firsta, P. P. . (2023). Malignancy Risk Index 4 (RMI 4) is better than RMI 3 as a predictor Advanced Epithelial Ovarian Carcinoma was used for NACT. Jurnal Ners, 7(1), 536–542. https://doi.org/10.31004/jn.v7i1.13495